{"id":"https://openalex.org/W2493501006","doi":"https://doi.org/10.1057/9780230289055_6","title":"New3 Cost Benefit Analysis of PBS Medications","display_name":"New3 Cost Benefit Analysis of PBS Medications","publication_year":2006,"publication_date":"2006-01-01","ids":{"openalex":"https://openalex.org/W2493501006","doi":"https://doi.org/10.1057/9780230289055_6","mag":"2493501006"},"language":"en","primary_location":{"id":"doi:10.1057/9780230289055_6","doi":"https://doi.org/10.1057/9780230289055_6","is_oa":false,"landing_page_url":"https://doi.org/10.1057/9780230289055_6","pdf_url":null,"source":{"id":"https://openalex.org/S4306463716","display_name":"Palgrave Macmillan UK eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310319703","host_organization_name":"Palgrave Macmillan","host_organization_lineage":["https://openalex.org/P4310319703","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Palgrave Macmillan","Springer Nature"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Normative Health Economics","raw_type":"book-chapter"},"volume":{"id":"https://openalex.org/W2504497945","display_name":"Normative Health Economics"},"type":"book-chapter","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035580856","display_name":"Sardar M. N. Islam","orcid":"https://orcid.org/0000-0001-9451-7390","observed_orcids":["https://orcid.org/0000-0001-9451-7390"]},"institutions":[{"id":"https://openalex.org/I71270174","display_name":"Victoria University","ror":"https://ror.org/04j757h98","country_code":"AU","type":"education","lineage":["https://openalex.org/I71270174"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Sardar M. N. Islam","raw_affiliation_strings":["Decision Sciences and Modelling Program, Victoria University, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Decision Sciences and Modelling Program, Victoria University, Australia","institution_ids":["https://openalex.org/I71270174"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033494139","display_name":"Christine Suet Yee Mak","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I71270174","display_name":"Victoria University","ror":"https://ror.org/04j757h98","country_code":"AU","type":"education","lineage":["https://openalex.org/I71270174"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Christine Suet Yee Mak","raw_affiliation_strings":["Decision Sciences and Modelling Program, Victoria University, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Decision Sciences and Modelling Program, Victoria University, Australia","institution_ids":["https://openalex.org/I71270174"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I71270174"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"133","last_page":"165"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9814000129699707,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9814000129699707,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.01640000008046627,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10841","display_name":"Economic and Environmental Valuation","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cost-benefit-analysis","display_name":"cost-benefit analysis","score":0.7319999933242798},{"id":"https://openalex.org/keywords/pharmaceutical-benefits-scheme","display_name":"Pharmaceutical Benefits Scheme","score":0.6050000190734863},{"id":"https://openalex.org/keywords/welfare-economics","display_name":"welfare economics","score":0.8240000009536743},{"id":"https://openalex.org/keywords/pharmaceutical-benefits-advisory-committee","display_name":"Pharmaceutical Benefits Advisory Committee","score":0.8700000047683716},{"id":"https://openalex.org/keywords/drug-reimbursement-decisions","display_name":"drug reimbursement decisions","score":0.6299999952316284},{"id":"https://openalex.org/keywords/health-technology-assessment","display_name":"health technology assessment","score":0.47600001096725464}],"concepts":[{"id":"https://openalex.org/C44725695","wikidata":"https://www.wikidata.org/wiki/Q288156","display_name":"Normative","level":2,"score":0.6953527927398682},{"id":"https://openalex.org/C127454912","wikidata":"https://www.wikidata.org/wiki/Q942582","display_name":"Cost\u2013benefit analysis","level":2,"score":0.597282886505127},{"id":"https://openalex.org/C2983830276","wikidata":"https://www.wikidata.org/wiki/Q942582","display_name":"Cost benefit","level":2,"score":0.574241578578949},{"id":"https://openalex.org/C162118730","wikidata":"https://www.wikidata.org/wiki/Q1128453","display_name":"Actuarial science","level":1,"score":0.5317087769508362},{"id":"https://openalex.org/C536738050","wikidata":"https://www.wikidata.org/wiki/Q3249071","display_name":"Social Welfare","level":2,"score":0.4861006736755371},{"id":"https://openalex.org/C2983335822","wikidata":"https://www.wikidata.org/wiki/Q942582","display_name":"Cost analysis","level":2,"score":0.47259220480918884},{"id":"https://openalex.org/C3017489713","wikidata":"https://www.wikidata.org/wiki/Q4686866","display_name":"Advisory committee","level":2,"score":0.46954283118247986},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.38156697154045105},{"id":"https://openalex.org/C100001284","wikidata":"https://www.wikidata.org/wiki/Q2248246","display_name":"Public economics","level":1,"score":0.3753971755504608},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.33899885416030884},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.3250621557235718},{"id":"https://openalex.org/C42475967","wikidata":"https://www.wikidata.org/wiki/Q194292","display_name":"Operations research","level":1,"score":0.273761123418808},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.1870269477367401},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.10836297273635864},{"id":"https://openalex.org/C187736073","wikidata":"https://www.wikidata.org/wiki/Q2920921","display_name":"Management","level":1,"score":0.09273427724838257},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.08201608061790466}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1057/9780230289055_6","doi":"https://doi.org/10.1057/9780230289055_6","is_oa":false,"landing_page_url":"https://doi.org/10.1057/9780230289055_6","pdf_url":null,"source":{"id":"https://openalex.org/S4306463716","display_name":"Palgrave Macmillan UK eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310319703","host_organization_name":"Palgrave Macmillan","host_organization_lineage":["https://openalex.org/P4310319703","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Palgrave Macmillan","Springer Nature"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Normative Health Economics","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4254959429","https://openalex.org/W3185268925","https://openalex.org/W2501941009","https://openalex.org/W2734910518","https://openalex.org/W4390129222","https://openalex.org/W1987678351","https://openalex.org/W103167597","https://openalex.org/W2061556311","https://openalex.org/W4388364412","https://openalex.org/W1506085565"],"abstract_inverted_index":{"In":[0],"this":[1],"chapter,":[2],"six":[3],"medications":[4],"are":[5],"selected":[6],"for":[7],"hypothetical":[8],"cost":[9,32,38],"benefit":[10,33,39],"analysis":[11,34,40],"under":[12,18,41],"the":[13,19,27,36,42],"type":[14],"of":[15,30,47],"criteria":[16],"listed":[17],"Pharmaceutical":[20],"Benefit":[21],"Advisory":[22],"Committee":[23],"(PBAC)":[24],"submission":[25],"guidelines,":[26],"standard":[28],"approach":[29,46],"financial":[31],"and":[35],"new3":[37,48],"normative":[43],"social":[44],"choice":[45],"welfare":[49],"economics.":[50]},"counts_by_year":[],"updated_date":"2026-10-10T09:11:00.788812","created_date":"2016-08-23T00:00:00"}